| 2011-09-14 | Plus Therapeutics, Inc. PSTV | director | 5,000 0.0005% | $3.20 | $15,992 | -24.79% | ||
| 2010-05-24 | Plus Therapeutics, Inc. PSTV | director | 5,000 0.0007% | $4.65 | $23,235 | +8.55% | ||
| 2010-05-19 | Plus Therapeutics, Inc. PSTV | director | 5,000 0.0007% | $4.83 | $24,164 | +6.95% | ||
| 2009-11-25 | Plus Therapeutics, Inc. PSTV | director | 5,000 0.0007% | $4.90 | $24,500 | -0.2% | ||
| 2009-11-24 | Plus Therapeutics, Inc. PSTV | director | 5,000 0.0007% | $4.74 | $23,700 | -0.1% | ||
| 2009-11-18 | Plus Therapeutics, Inc. PSTV | director | 20,000 0.003% | $4.25 | $84,900 | +16.51% | ||
| 2009-11-17 | Plus Therapeutics, Inc. PSTV | director | 5,000 0.0008% | $3.98 | $19,900 | +24.75% | ||
| 2009-11-12 | Plus Therapeutics, Inc. PSTV | director | 10,000 0.0015% | $3.50 | $35,000 | +44.02% | ||
| 2006-05-17 | Sale | Neurocrine Biosciences, Inc. NBIX | Executive VP and CFO | 230,962 0.6138% | $19.79 | $4.57M | -43.41% | |
| 2005-12-21 | Sale | Neurocrine Biosciences, Inc. NBIX | Executive VP and CFO | 20,000 0.0548% | $64.70 | $1.29M | -80.14% | |
| 2004-02-11 | Sale | Neurocrine Biosciences, Inc. NBIX | Executive VP and CFO | 20,000 0.056% | $56.71 | $1.13M | -13.44% |